Project Grant R03DE035990
- Federal Grant Award Summary The National Institute of Dental and Craniofacial Research (NIDCR), under its Oral Diseases and Disorders Research program (CFDA 93.121), awarded $440,275 to The Research Foundation For The State University Of New York (RF SUNY) on February 1, 2026, for a two-year project extending through January 31, 2028. The award supports basic research on transcriptional regulatory mechanisms governing salivary gland regeneration, with performance conducted at the University at...
- Federal Project Grant Award Summary Texas A&M University System Health Science Center received a $409,960 Project Grant from the National Institute of Dental and Craniofacial Research under the Oral Diseases and Disorders Research program (CFDA 93.121), awarded July 1, 2025, with a completion date of June 30, 2027. The grant funds the development of human salivary gland-on-a-chip (OOC) models designed to advance understanding and treatment of salivary gland hypofunction, or dry mouth...
- Federal Project Grant Award Summary The National Institute of Dental and Craniofacial Research (NIDCR) awarded a Project Grant totaling $427,625 to The Washington University (Office of Sponsored Research Services) effective February 6, 2026, through February 5, 2028, under the Oral Diseases and Disorders Research program (CFDA 93.121). The research project, titled "Radiation-Guided Theranostic Agents to Monitor Response to Oral Cancer Treatment," focuses on developing diagnostic and...
- Federal Grant Award Summary The University of South Alabama received a $429,000 Project Grant award from the National Institute of Dental and Craniofacial Research (NIDCR) under the Oral Diseases and Disorders Research program (CFDA 93.121), effective July 1, 2025 through June 30, 2027. This award supports research investigating phosphodiesterase 4 (PDE4) inhibition as a novel therapeutic approach for xerostomia and salivary gland dysfunction associated with Sjögren's Syndrome. The research...
- Federal Grant Award Summary The National Institute of Dental and Craniofacial Research (NIDCR) awarded a $110,676 Project Grant to Indiana University Indianapolis under the Oral Diseases and Disorders Research program (CFDA 93.121) for research on the function of zymogen granule 16B (ZG16B) in salivary glands. The award, effective December 1, 2025, through June 30, 2027, supports basic research investigating ZG16B, a jacalin-related lectin protein identified as significantly reduced in...
- Federal Grant Award Summary The National Institute of Dental and Craniofacial Research (NIDCR) awarded a Project Grant of $392,918 to the University of Wisconsin-Madison under the Oral Diseases and Disorders Research program (CFDA 93.121) on August 1, 2025, for a two-year project period concluding July 31, 2027. The research project focuses on developing microphysiological systems (MPS) to model Sjögren's disease (SjD) salivary gland pathogenesis. The primary deliverable is the creation of...
- Grant Award Summary The National Institute of Dental and Craniofacial Research (NIDCR), under the Oral Diseases and Disorders Research program (CFDA 93.121), awarded a $100,676 Project Grant to Icahn School of Medicine at Mount Sinai beginning December 1, 2025, with completion scheduled for June 30, 2028. This research initiative investigates the functional role of tissue-resident macrophages (TRMs) during salivary gland morphogenesis, addressing a significant gap in understanding how these...
- This $498,000 Project Grant awarded by the National Institute of Dental and Craniofacial Research (NIDCR) under the Oral Diseases and Disorders Research program (CFDA 93.121) supports a three-year research initiative (September 1, 2025 through August 31, 2028) to investigate cell fate determination processes in salivary gland development. The research addresses critical knowledge gaps in regenerative medicine by examining how cells commit to specific lineages during salivary gland morphogenesis,...
- Federal Grant Award Summary Award Details: The National Institute of Dental and Craniofacial Research (NIDCR) awarded Oregon Health & Science University a Project Grant totaling $524,669 under the Oral Diseases and Disorders Research program (CFDA 93.121). The award was obligated on June 1, 2026, with an ultimate completion date of February 28, 2031. Research Objectives and Deliverables: The grant funds a comprehensive research initiative investigating Streptococcus sanguinis extracellular...
- Federal Grant Award Summary The National Institute of Dental and Craniofacial Research awarded Louisiana State University Health Sciences Center-Shreveport a $401,500 Project Grant on June 17, 2025, under the Oral Diseases and Disorders Research program (CFDA 93.121) to investigate SARS-CoV-2 tropism and immunomodulation in salivary gland tissue. The two-year research project, scheduled for completion by June 16, 2027, will deliver fundamental scientific research examining how SARS-CoV-2...
The National Institute of Dental and Craniofacial Research (NIDCR) awarded the University of Missouri System $304,650 under the Oral Diseases and Disorders Research program (CFDA 93.121) for a two-year Project Grant effective July 6, 2026, through July 5, 2028. The award funds research to engineer salivary gland cell sheets that restore secretory function in radiation-damaged salivary tissue. The research addresses a critical clinical need, as over 82,000 head and neck cancer patients annually undergo radiation therapy that permanently damages salivary glands, resulting in hyposalivation with limited effective treatments. The investigative team will develop and validate temperature-responsive cell sheet technology—in which primary salivary gland cells cultured on polymer-coated dishes detach without enzymatic treatment and maintain extracellular matrix and cell-cell junctional proteins—to restore tissue organization and function in irradiated mouse models. The core deliverables include demonstration of functional salivary gland restoration through cell sheet transplantation and mechanistic characterization of juxtacrine and paracrine signaling pathways that mediate the therapeutic effects. This translational research effort aims to establish cell sheet engineering as a viable regenerative treatment alternative to currently ineffective saliva substitutes and temporary secretory agonists, with potential for clinical application in head and neck cancer survivorship care.Federal Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $304.7k | 7/8/26 |